N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide
![N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide Structure](CAS/GIF/885069-14-7.gif)
- CAS No.
- 885069-14-7
- Chemical Name:
- N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide
- Synonyms
- N-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzothiazol-2-yl]acetamide;AcetaMide,N-[6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-2-benzothiazolyl]-;N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide
- CBNumber:
- CB62524955
- Molecular Formula:
- C15H19BN2O3S
- Molecular Weight:
- 318.2
- MDL Number:
- MFCD22571502
- MOL File:
- 885069-14-7.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| N-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-benzothiazolyl]acetamide 95% | AA003SAY | 50mg | $511 |
| N-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-benzothiazolyl]acetamide 95% | AA003SAY | 100mg | $880 |
| N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | CD11033756 | 250mg | $338 |
| N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | CD11033756 | 1g | $845 |
| N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | CM218025 | 250mg | $444 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H312-H332 |
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501 |
N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| aablocks | AA003SAY | N-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-benzothiazolyl]acetamide 95% | 885069-14-7 | 50mg | $511 | 2026-05-28 | Buy |
| aablocks | AA003SAY | N-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-benzothiazolyl]acetamide 95% | 885069-14-7 | 100mg | $880 | 2026-05-28 | Buy |
| Crysdot | CD11033756 | N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | 885069-14-7 | 250mg | $338 | 2026-05-26 | Buy |
| Crysdot | CD11033756 | N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | 885069-14-7 | 1g | $845 | 2026-05-26 | Buy |
| Chemenu | CM218025 | N-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide 97% | 885069-14-7 | 250mg | $444 | 2026-05-26 | Buy |
N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide Chemical Properties,Uses,Production
Synthesis
![N-(6-bromobenzo[d]thiazol-2-yl)acetamide](/CAS/GIF/16628-26-5.gif)
16628-26-5
73183-34-3
![N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide](/CAS/GIF/885069-14-7.gif)
885069-14-7
General procedure for the synthesis of 2-acetamido benzothiazole-6-boronic acid from 6-bromo-2-acetamidobenzothiazole and pinacol ester of bis(pinacolato): N-(6-bromobenzo[d]thiazol-2-yl)acetamide (2.10 g, 7.75 mmol), bis(pinacolato)diboron (3.00 g, 11.8 mmol), Pd(dppf)Cl2 ( 560 mg, 0.77 mmol) and KOAc (3.00 g, 30.6 mmol) were dissolved in DMSO (50 mL) and the reaction was stirred at 90 °C for 8 h under N2 atmosphere. After completion of the reaction, it was cooled to room temperature and the reaction mixture was filtered. The filtrate was diluted with ethyl acetate (200 mL), washed sequentially with brine (20 mL x 3) and the organic phase was dried over anhydrous Na2SO4 and concentrated. The resulting residue was washed with petroleum ether (50 mL) to give the light brown solid product 2-acetamido benzothiazole-6-boronic acid (2.40 g, 97% yield).
References
[1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3665 - 3670
[2] Patent: WO2018/17435, 2018, A1. Location in patent: Paragraph 0092-0093
[3] Patent: CN107753483, 2018, A. Location in patent: Paragraph 0036; 0038; 0041-0042
[4] Patent: US2015/225407, 2015, A1. Location in patent: Paragraph 0410
[5] Patent: WO2010/100144, 2010, A1. Location in patent: Page/Page column 101-102
N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide Preparation Products And Raw materials
N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)acetamide Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Jilin Chinese Academy of Sciences-yanshen Technology | +undefined18143011203 | info@chemextension.com | China | 42056 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131956 | 58 |
| Beijing Ouhe Technology Co., Ltd | 13552068683 13522913783 | 2355560935@qq.com | China | 11780 | 60 |
| Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66113011 17714375163 | cfzhang@aikonchem.com | China | 19906 | 55 |
| ShangHai AmK Pharmaceutical Technology Co., Ltd. | 微信 17321281695 18019252918 | sale@amkchem.com | China | 14983 | 55 |
| DebyeTec.com Inc. | 18086626237 18086626237 | 2693528373@qq.com | China | 2937 | 56 |
| Shanghai Wishpharma Co.,Ltd. | 021-56789108 18694902053 | 95413064@qq.com | China | 294 | 56 |
| Shanghai Kaiwei Chemical Technology Co., Ltd. | 021-58461859 15821823057 | service@aiviche.com | China | 49312 | 58 |
| Shanghai Haohong Pharmaceutical Co., Ltd. | 400-8210725 4008210725 | malulu@leyan.com | China | 54995 | 58 |
| Hebei Weite Medical Technology Co., Ltd | 13180081292 13180081292 | contact@wetogethermed.com | China | 7754 | 58 |
